Evaluating percutaneous support for cardiogenic shock: data shock and sticker shock

Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock.

Despite a high rate of early revascularization and use of intra-aortic balloon pump counterpulsation therapy, the prognosis of patients with cardiogenic shock has remained poor. In the hopes of improving outcomes, clinicians are increasingly turning to percutaneous left and right mechanical circulatory support devices. Until recently, the evidence base for these devices had consisted only of ob...

Percutaneous Mechanical Support in Cardiogenic Shock: A Review

Cardiogenic shock (CS) is a life-threatening condition associated with significant morbidity and mortality. Pharmacological therapy is often the first line of treatment but mechanical support can provide substantial hemodynamic improvement in refractory CS. Percutaneous mechanical support devices are placed in a minimally invasive manner and provide life-saving assistance to the failing myocard...

Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery.

Over the past 2 decades, innovation in the realm of mechanical ventricular assist devices (VADs) has altered the management of cardiogenic shock (CS). Percutaneous VADs (PVADs) allow emergent and effective ventricular unloading while providing sufficient systemic perfusion pressure to reverse end-organ dysfunction. Despite relatively few randomized trials evaluating these devices, some cardiova...

Percutaneous coronary intervention in cardiogenic shock.

853 A myocardial infarction (AMI) complicated by cardiogenic shock (CS) has an incidence of 7-10 % of patients despite all the advances in reperfusion and antithrombotic therapy. Mortality associated with CS ranges between 45-80 %. The commonest cause of CS is primary left ventricular failure, the others being some of the mechanical complications of AMI, namely free wall rupture, papillary musc...

Cardiogenic Shock